News
In an interview with PBS' 'NewsHour' co-anchor and co-managing editor Amna Nawaz on Thursday, Marty Makary expanded on his ...
AbbVie CEO Rob Michael said the company will invest $10 billion in the US over the next decade, as the threat of ...
HHS Secretary Robert F. Kennedy Jr. said Friday that 35 states had signed up to participate in a new payment model meant to ...
Amgen is the latest in a series of biopharma companies to tout a massive new US-based investment in manufacturing.
A federal district court in Texas on Thursday denied a request for a preliminary injunction from the Outsourcing Facilities ...
ALX Oncology’s efforts to progress a CD47 combo hit a major speed bump. The company said Friday that two trials ...
Merck KGaA in talks to acquire SpringWorks Therapeutics for $47/share ($3.5B), gaining cancer drugs Ogsiveo and Gomekli. Deal ...
One quarter after AbbVie raised future sales estimates due to the successes of its immunology portfolio, the company again ...
Sanofi reports Q1 growth with Altuviiio sales doubling to €251M and Dupixent reaching €3.5B; company terminates two cancer ...
During Thursday’s first-quarter earnings call, Chris Boerner made his strongest comments yet that Bristol Myers intends to be ...
But the company is not ruling out future deals, even in its metabolic unit, which recently saw a major partnership with ...
Lotte Biologics, Ypsomed, PCI Pharma, Samsung Biologics, Catalent & Ferring share manufacturing updates: new ADC services, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results